No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
TNYA Tenaya Therapeutics
- 4.220
- -0.160-3.65%
Close Apr 25 16:00 ET
- 4.230
- +0.010+0.24%
Post 17:03 ET
331.34MMarket Cap-2511P/E (TTM)
4.300High3.970Low384.57KVolume4.250Open4.380Pre Close1.61MTurnover0.90%Turnover RatioLossP/E (Static)78.52MShares8.09152wk High2.38P/B180.35MFloat Cap1.66052wk Low--Dividend TTM42.74MShs Float32.000Historical High--Div YieldTTM7.53%Amplitude1.640Historical Low4.180Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Institutions Own 33% of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Shares but Private Equity Firms Control 44% of the Company
Tenaya Therapeutics' Strategic Advantages in Cardiovascular Genetic Medicine Garner Buy Rating
Optimistic Buy Rating for Tenaya Therapeutics Based on Promising Gene Therapy Pipeline and Upcoming Clinical Milestones
20 Countries With the Highest Heart Disease Deaths Per Capita
Chardan Capital Reiterates Buy on Tenaya Therapeutics, Maintains $20 Price Target
Chardan Capital analyst Geulah Livshits reiterates Tenaya Therapeutics with a Buy and maintains $20 price target.
Analysts' Opinions Are Mixed on These Healthcare Stocks: Vera Therapeutics (VERA), Tyra Bioscience (TYRA) and Tenaya Therapeutics (TNYA)
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg